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Campylobacter jejuni infections have a high prevalence worldwide and represent a
significant socioeconomic burden. C. jejuni can cross the intestinal epithelial barrier as
visualized in biopsies derived from human patients and animal models, however, the
underlying molecular mechanisms and associated immunopathology are still not well
understood. We have recently shown that the secreted serine protease HtrA (high
temperature requirement A) plays a key role in C. jejuni cellular invasion and transmigration
across polarized epithelial cells in vitro. In the present in vivo study we investigated the
role of HtrA during C. jejuni infection of mice. We used the gnotobiotic IL-10−/− mouse
model to study campylobacteriosis following peroral infection with the C. jejuni wild-type
(WT) strain NCTC11168 and the isogenic, non-polar NCTC11168htrA deletion mutant. Six
days post infection (p.i.) with either strain mice harbored comparable intestinal C. jejuni
loads, whereas ulcerative enterocolitis was less pronounced in mice infected with the
htrA mutant strain. Moreover, htrA mutant infected mice displayed lower apoptotic
cell numbers in the large intestinal mucosa, less colonic accumulation of neutrophils,
macrophages and monocytes, lower large intestinal nitric oxide, IFN-γ, and IL-6 as well
as lower TNF-α and IL-6 serum concentrations as compared to WT strain infected mice
at day 6 p.i. Notably, immunopathological responses were not restricted to the intestinal
tract given that liver and kidneys exhibited mild histopathological changes 6 days p.i. with
either C. jejuni strain. We also found that hepatic and renal nitric oxide levels or renal
TNF-α concentrations were lower in the htrA mutant as compared to WT strain infected
mice. In conclusion, we show here that the C. jejuni HtrA protein plays a pivotal role in
inducing host cell apoptosis and immunopathology during murine campylobacteriosis in
the gut in vivo.
Keywords: ulcerative enterocolitis, colonization resistance, innate immunity, host-pathogen-interaction, bacterial
translocation, intestinal immunopathology, extra-intestinal immune responses, systemic immune responses
INTRODUCTION
Campylobacter species are classical zoonotic pathogens, living
predominantly as commensals in the gastrointestinal tract of
a wide range of birds and mammals, including agriculturally
important animals (Young et al., 2007; van Putten et al., 2009;
Dasti et al., 2010; Gaynor and Szymanski, 2012). Thus, con-
taminated animal food products serve as a major source of
Campylobacter infections in humans (Alter et al., 2011; Oyarzabal
and Backert, 2011). The most prevalent Campylobacter species in
human disease is C. jejuni, which represents the leading cause of
bacterial infections in the gut and acute diarrheal disease world-
wide (Friedman et al., 2000; Young et al., 2007; Mukhopadhya
et al., 2011). Disease outcome in humans varies from mild,
non-inflammatory, self-limiting diarrhea to severe, inflamma-
tory, bloody diarrhea lasting for several weeks (Young et al.,
2007; Oyarzabal and Backert, 2011). In addition, in a minority of
infected persons,C. jejuni can be associated with the development
of reactive arthritis and peripheral neuropathies, the Miller–
Fisher and Guillain–Barrè syndromes, respectively (Nachamkin
et al., 2008; Szymanski and Gaynor, 2012). In vivo and in vitro
research studies performed in the last two decades revealed that
C. jejuni exhibits various remarkable properties during infec-
tion. An important feature of C. jejuni is their ability to bind
to and enter human gut epithelial cells causing intestinal tissue
damage (Ó’Cróinín and Backert, 2012). C. jejuni adherence to
epithelial cells has been shown to involve a variety of proposed
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and confirmed outer membrane adhesins, including JlpA, PEB1,
CadF, FlpA among others (Pei et al., 1998; Konkel et al., 2005; Poly
and Guerry, 2008; Novik et al., 2010; Eucker and Konkel, 2012).
C. jejuni invasion of cultured INT-407 and other cell lines has
been observed to induce rearrangements of the host cytoskele-
ton by small Rho GTPases, Rac1, and Cdc42, which are directly
linked to bacterial uptake (Krause-Gruszczynska et al., 2007a,
2011; Boehm et al., 2011; Eucker and Konkel, 2012). C. jejuni can
also cross the intestinal epithelial barrier as visualized in biop-
sies derived from human patients (Backert et al., 2013). Efforts
with rodent and chicken infection model systems have been made
to study pathogenicity mechanisms of C. jejuni in vivo, but each
animal system has diverse limitations. Currently, disease manifes-
tation such as gastroenteritis mimicking human camplylobacte-
riosis can be achieved in distinct infection models such as con-
ventionally colonized infant wild-type (WT) and gnotobiotic IL-
10−/− mice (Gaynor and Szymanski, 2012; Haag et al., 2012a,b).
Notably, when infecting with a C. jejuni B2 strain (which is
well known for its effective colonization properties) immediately
after weaning, approximately 90% of conventionally colonized 3-
weeks-old infant mice developed self-limiting enterocolitis within
6–8 days resolving within 2 weeks post infection (p.i.) (Haag et al.,
2012b). However, when infecting with other C. jejuni strains than
B2 such as strains 81–176 or 11168, a huge variability in colo-
nization and disease development could be observed in the infant
mouse model. Irrespective of the C. jejuni strain, however, gno-
tobiotic IL-10−/− mice get readily colonized by the pathogen at
high loads following peroral infection. Very similar to immuno-
compromised patients, infected mice develop non-self limiting
wasting ulcerative enterocolitis within 1 week p.i. (Haag et al.,
2012a; Heimesaat et al., 2014). Importantly, the intestinal inflam-
mation induced by C. jejuni in mice and humans is aggravated
by C. jeuni lipooligosaccharide (LOS) via Toll-like-receptor-4
(TLR-4), as we could show previously (Haag et al., 2012a).
We and others have recently reported that the HtrA (high
temperature requirement A) protein of C. jejuni is a novel vir-
ulence factor (Brøndsted et al., 2005; Bæk et al., 2011a,b; Boehm
et al., 2012; Hoy et al., 2012). Bacterial HtrA proteins represent a
class of conserved heat shock induced serine proteases with addi-
tional chaperone activity, which were shown to have a significant
impact on the virulence capabilities of various bacterial pathogens
(Ingmer and Brøndsted, 2009; Backert et al., 2013; Frees et al.,
2013; Skorko-Glonek et al., 2013). For example, it was demon-
strated that growth of the htrAmutant was severely impaired at
44◦C as compared to WT C. jejuni and tolerance of the mutant
bacteria against oxygen stress is strongly reduced (Brøndsted
et al., 2005). In many different bacterial species, HtrA proteins
are localized in the periplasm, where they form proteolytically
active multimers with crucial function in the intracellular protein
quality control machinery (Clausen et al., 2002, 2011). The class
of HtrA proteins typically consists of a signal peptide, a trypsin-
like serine protease domain and one or two PDZ [post synaptic
density protein (PSD95), Drosophila disc large tumor suppres-
sor (Dlg1), and zonula occludens-1 protein (ZO-1)] domains
for protein-protein interactions (Kim and Kim, 2005). For long
time it was assumed that HtrA family members are strictly acting
intracellularly within the bacteria. However, very recently we have
discovered a remarkably new feature of HtrA during infection.
In various ε-proteobacteria such as H. pylori and C. jejuni, HtrA
is actively secreted into the extracellular environment, where it
cleaves the cell surface adhesion protein and tumor-suppressor
E-cadherin (Hoy et al., 2010, 2012; Boehm et al., 2012, 2013).
Infection experiments with C. jejuni in vitro indicated that HtrA
can open the cell-to-cell junctions in cell monolayers by cleaving-
off the∼90-kDa extracellular NTF domain of E-cadherin (Boehm
et al., 2012; Hoy et al., 2012). Deletion of the htrA gene leads to
a defect in E-cadherin shedding and transmigration of C. jejuni
across monolayers of polarized human MKN-28 epithelial cells
in vitro (Boehm et al., 2012). However, the potential relevance of
the htrA gene for the interaction ofC. jejuniwith the host immune
system has not been investigated so far.
To address this important question, we applied in the present
study the C. jejuni infection model system of gnotobiotic
IL-10−/− mice. Here we investigated the role of C. jejuni HtrA in
(i) colonization capacity, (ii) translocation, (iii) clinical outcome,
(iv) intestinal inflammation, and (v) extra-intestinal sequelae
including systemic immune responses following infection of gno-
tobiotic IL-10−/− mice with the C. jejuni WT strain NCTC11168
and the isogenic knockout mutant strain NCTC11168htrA.
MATERIALS AND METHODS
ETHICS STATEMENT
All animal experiments were conducted according to the
European Guidelines for animal welfare (2010/63/EU) with
approval of the commission for animal experiments headed by
the “Landesamt für Gesundheit und Soziales” (LaGeSo, Berlin,
Germany; registration numbers G0123/12). Animal welfare was
monitored twice daily by assessment of clinical conditions.
C. JEJUNI STRAINS AND GENETIC COMPLEMENTATION OF HTRA
For genetic complementation of htrA, we used the pCam-148
chromosomal C. jejuni complementation vector kindly pro-
vided by Dr. Dennis Linton (University Manchester, UK).
Briefly, pCam-148 contains a 2,178 bp fragment of C. jejuni
NCTC11168 genomic DNA (position 205,297 to 207,475)
cloned into the SmaI restriction site of plasmid pUC18. pCam-
148 contains a singular SpeI restriction site in the C. jejuni
sequence within the pseudogene downstream of Cj0208. We
used this SpeI site to introduce three additional restriction sites
(NotI, MluI, and NruI) using the primer annealing approach.
Subsequently, we amplified by PCR a 1,694 bp fragment of
the htrA gene of C. jejuni NCTC11168, including 200-bp
upstream and 75-bp downstream sequences using the primers
HtrA-1 5′GTTATATTTCCTTAAAAATTTTTAC and HtrA-2
5′AGTTTTCCTTTATTTTAAACTTAAT. The resulting PCR
product was cloned into the pSB-249 vector containing flanking
NotI and MluI sites, respectively. The htrA gene was then
further subcloned into the NotI and MluI sites of pCam-148.
As a selection marker, we used a 795-bp kanamycin-resistant
Aph cassette with its own promoter from plasmid pRYSK12
(kindly provided by Dr. Sabine Kienesberger, University Graz,
Austria). This Aph cassette was cloned into the MluI and NruI
restriction sites of pCam-148 next to the NCTC11168 htrA
gene. The resulting htrA complementation vector was called
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pSB-250. pSB-250 was then transformed into the C. jejuni
NCTC11168htrA deletion mutant (Boehm et al., 2012, 2013)
and called NCTC11168htrA/htrA. Correct integration of htrA
in the C. jejuni chromosome was confirmed by PCR and standard
sequencing. Expression of HtrA proteins was verified by Western
blotting.
GROWTH OF C. JEJUNI STRAINS ON MH AGAR PLATES
C. jejuni NCTC11168 WT, NCTC11168htrA and
NCTC11168htrA/htrA were grown overnight on Müller-
Hinton (MH) agar plates at 37◦C under microaerobic conditions
using CampyGen gas packs (Oxoid, Wesel, Germany). Bacterial
cells were harvested using brain heart infusion broth, and the
OD600 was adjusted to 0.1. Subsequently, serial dilutions were
made, and 10μl volumes of the 10−1, 10−2, 10−3, 10−4, 10−5,
and 10−6 dilutions were spotted onto three MH agar plates,
which were incubated under microaerobic conditions using for
3 days at 42 or 44◦C, or at 42◦C in the presence of 18% O2 as
described (Brøndsted et al., 2005). Experiments were repeated at
least three times.
CASEIN ZYMOGRAPHY
Bacterial lysates, culture supernatants or recombinant HtrA were
separated under non-reducing conditions in gels containing
casein. Subsequently, gels were renatured in 2.5% Triton-X-100
and equilibrated in developing buffer (Boehm et al., 2012; Hoy
et al., 2012). Caseinolytic activity was visualized by staining with
0.5% Coomassie Blue R250.
MICE
IL-10−/− knockout mice (in C57BL/10 background, B10)
were bred and maintained under specific pathogen-free (SPF)
conditions in the facilities of the “Forschungsinstitut für
Experimentelle Medizin” (FEM, Charité - Universitätsmedizin,
Berlin, Germany). To eradicate the commensal gut flora, mice
were transferred to sterile cages and treated by adding a
mix of ampicillin (1 g/L; Ratiopharm), vancomycin (500mg/L;
Cell Pharm), ciprofloxacin (200mg/L; Bayer Vital), imipenem
(250mg/L; MSD), and metronidazole (1 g/L; Fresenius) to the
drinking water ad libitum starting at 3 weeks of age right after
weaning (Heimesaat et al., 2006; Haag et al., 2012a). Age matched
female mice were subjected to the quintuple antibiotic treatment
for approximately 4 months before the infection experiments.
C. JEJUNI INFECTION OF MICE
Mice were infected with 109 viable colony forming units (CFU) of
theC. jejuni parental strain NCTC11168WT strain or the isogenic
mutant strain NCTC11168htrA by gavage in a total volume of
0.3mL PBS on 2 consecutive days (day 0 and 1) as described
(Haag et al., 2012a,b).
CLINICAL SCORING
To assess clinical signs of C. jejuni induced infection on a
daily basis, a standardized cumulative clinical score (maxi-
mum 12 points, addressing the occurrence of blood in feces
(0 points: no blood; 2 points: microscopic detection of blood
using Haemoccult, Beckman Coulter / PCD, Krefeld, Germany;
4 points: overt blood visible), diarrhea (0: formed feces; 2: pasty
feces; 4: liquid feces), and the clinical aspect (0: normal; 2:
ruffled fur, less locomotion; 4: isolation, severely compromised
locomotion, pre-final aspect) was used (Haag et al., 2012a,b).
SAMPLING PROCEDURES, DETERMINATION OF COLONIC LENGTH,
AND HISTOPATHOLOGY
Mice were sacrificed by isofluran treatment (Abbott, Germany).
Cardiac blood and tissue samples from mesenteric lymph nodes
(MLNs), spleen, liver, kidneys, and intestinal tract (duode-
num, ileum, and colon) were removed under sterile conditions.
Absolute large intestinal lengths were determined by measuring
the distance from the ascending colon leaving the caecum to
the rectum by a ruler and expressed in cm. Intestinal samples
from each mouse were collected in parallel for histopatholog-
ical, immunohistochemical, microbiological, and immunologi-
cal analyses. Immunohistopathological changes were determined
in samples derived from colon, liver and kidney that were
immediately fixed in 5% formalin and embedded in paraffin.
Sections (5μm) were stained with hematoxylin and eosin (H&E),
examined by light microscopy (magnification 100× and 400×)
and histopathological changes quantitatively assessed applying
respective histopathological scoring systems by two independent
double-blinded investigators. In brief:
Colonic Histopathology (max. 4 points; according to Paclik
et al., 2008): 0: no inflammation; 1: single isolated cell infil-
trates within the mucosa,; no epithelial hyperplasia; 2: mild
scattered to diffuse cell infiltrates within the mucosa and sub-
mucosa; mild epithelial hyperplasia; starting loss of goblet cells;
3: cell infiltrates within mucosa, submucosa, and sometimes
transmural; epithelial hyperplasia; loss of goblet cells; 4: cell
infiltrates within mucosa, submucosa, and transmural; severe
inflammation; loss of goblet cells, loss of crypts; ulcerations;
severe epithelial hyperplasia.
Hepatic Histopathology (max. 9 points; modified Ishak score,
Ishak et al., 1995): Lobular inflammation: 0: normal; 1: minimal
inflammation (few inflammatory infiltrates); 2: mild inflamma-
tion (increased inflammatory cells, but less pyknotic necrosis);
3: moderate inflammation (marked increase in inflammatory
cells and lots of pyknotic necroses); 4: severe inflammation
(necrosis); 5: severe inflammation (plus bridging necroses).
Portal inflammation: 0: normal; 1: mild inflammation (<1/3
of portal tracts); 2: moderate inflammation (ca. 1/2 of por-
tal tracts); 3: severe inflammation (>2/3 of portal tracts); 4:
severe inflammation (plus portal inflammation disperse into
parenchyma).
Renal Histopathology (max. 4 points; according to Appel et al.,
1978): 0: normal glomerulus; 1: focal and mild hypercellularity
(normal= 3 per segment); 2: multifocal andmoderate hypercel-
lularity with capillary dilatation and mild hyalinosis; 3: diffuse
hypercellularity (>50% of the tuft) and capillary aneurysm;
4: extensive sclerosis/crescents (>3 cell layer), tuft obliteration,
collapse.
IMMUNOHISTOCHEMISTRY
In situ immunohistochemical analysis of 5μm thin colonic paraf-
fine sections was performed as described previously (Heimesaat
et al., 2010, 2013; Bereswill et al., 2011; Haag et al., 2012a,b).
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Primary antibodies against cleaved caspase-3 (Asp175, Cell
Signaling, USA, 1:200), Ki67 (TEC3, Dako, Denmark, 1:100),
CD3 (M-20, Santa Cruz, dilution 1:1000), myeloperoxidase-7
(MPO-7, # A0398, Dako, 1:500), F4/80 (# 14-4801, clone BM8,
eBioscience, 1:50), FOXP3 (FJK-16s, eBioscience, 1:100), and
B220 (eBioscience, San Diego, CA, USA, 1:200) were used. For
each animal, the average number of positively stained cells within
at least six high power fields (HPF, 0.287mm2; 400× magni-
fication) were determined microscopically by two independent
double-blinded investigators and subjected to statistical analysis
as indicated below.
QUANTITATIVE ANALYSIS OF C. JEJUNI AND BACTERIAL
TRANSLOCATION INTO OTHER ORGANS
Live C. jejuni were detected at time of necropsy (day 6 p.i.)
in luminal samples taken from the duodenum, ileum, or colon
diluted in sterile PBS by culture as described earlier (Bereswill
et al., 2011). To quantify bacterial translocation into different
organs, MLNs, spleen, liver, and kidney were homogenized in
sterile PBS and analyzed by cultivating in dilution series on kar-
mali agar (Oxoid,Wesel, Germany) in amicroaerobic atmosphere
at 37◦C for at least 48 h (Heimesaat et al., 2013). In addition,
0.5mL of cardiac blood was streaked out immediately on karmali
agar. The respective weights of luminal fecal or tissue samples
were determined by the difference of the sample weights before
and after asservation.
CYTOKINE DETECTION IN SERUM SAMPLES AND CULTURE
SUPERNATANTS OF EX VIVO BIOPSIES TAKEN FROM COLON,
MESENTERIC LYMPH NODES, SPLEEN, LIVER, AND KIDNEY
Colonic biopsies and kidneys were cut longitudinally and the for-
mer washed in PBS. MLNs or strips of approximately 1 cm2 colon
and liver tissue and additionally half of spleen and kidney were
placed in 24-flat-bottom well culture plates (Nunc, Wiesbaden,
Germany) containing 500μL serum-free RPMI 1640 medium
supplemented with penicillin (100U/mL) and streptomycin
(100μg/mL; PAA Laboratories). After 18 h of incubation at 37◦C,
culture supernatants as well as serum samples were analyzed for
IFN-γ, TNF-α, and IL-6 by the Mouse Inflammation Cytometric
Bead Assay (CBA; BD Biosciences) on a BD FACS Canto II flow
cytometer (BD Biosciences). Nitric oxide (NO) was determined
by Griess reaction as described earlier (Heimesaat et al., 2006).
QUANTITATIVE REAL-TIME PCR (QRT-PCR)
RNA was isolated from colonic tissues using the RNeasy Mini Kit
(Qiagen). mRNA was reversed transcribed and analyzed in trip-
licate assays by TaqMan PCR using a sequence detection system
(ABI Prism 7700; Applied Biosystems) as described previously
(Wolk et al., 2002; Munoz et al., 2009). For detection of murine
MUC-2 assays including double-fluorescent probes in combina-
tion with assays for the mouse housekeeping gene hypoxanthine
phosphoribosyltransferase (HPRT) were purchased from Applied
Biosystems. Expression levels were calculated relative to the HPRT
expression.
ANTIBODIES ANDWESTERN BLOTTING
C. jejuni cell pellets were lysed and proteins were separated
by SDS-PAGE (Krause-Gruszczynska et al., 2007b; Wiedemann
et al., 2012). The polyclonal rabbit α-HtrA antibody was
raised against a conserved peptide corresponding to amino
acid (aa) residues 288–301: C-QGDTKKAYKNQEGA. The α-
CiaB antibody was generated against the epitope 597–610
(C-EIDNSGEFERYKKK) and the α-MOMP antibody against
aa residues 400–413 (C-NLDQGVNTNESADH) in the corre-
sponding proteins, respectively. All three peptides were con-
jugated to Limulus polyphemus haemocyanin carrier protein,
and two rabbits each were immunized by Biogenes GmbH
(Berlin, Germany) using standard protocols (Tegtmeyer et al.,
2013). The resulting antiserum was affinity-purified and the
specificity against the proteins in C. jejuni was confirmed by
Western blotting (Tegtmeyer et al., 2011; Backert and Hofreuter,
2013). Horseradish peroxidase-conjugated anti-rabbit polyvalent
sheep immunoglobulin was used as secondary antibody (DAKO
Denmark A/S, DK-2600 Glostrup, Denmark). Blots were devel-
oped with ECL Plus Western blot reagents (GE Healthcare, UK
limited Amersham Place, UK) as described (Conradi et al., 2012;
Hirsch et al., 2012).
STATISTICAL ANALYSIS
Mean values, medians, and levels of significance were deter-
mined using Mann-Whitney-U-test. Two-sided probability (P)
values ≤ 0.05 were considered significant. All experiments were
repeated various times as indicated in the corresponding figure
legends.
RESULTS
HTRA DOES NOT AFFECT THE COLONIZATION CAPACITY OF C. JEJUNI
IN GNOTOBIOTIC IL-10−/− MICE
In order to eradicate the chronic colitogenic stimulus derived
from the commensal intestinal microbiota, IL-10−/− mice were
pre-treated with a quintuple antibiotic regimen for approxi-
mately 4 months starting immediately after weaning (Haag et al.,
2012a). The resulting gnotobiotic IL-10−/− mice were then per-
orally infected with 109 CFU of either C. jejuni NCTC11168
WT or isogenic htrA mutant (NCTC11168htrA) strain, each
grown to stationary phase on 2 consecutive days (day 0 and 1).
Control blots demonstrate that equal amounts of C. jejuni
were infected per sample and HtrA is not expressed in the
htrA mutant as expected (Figure 1A). We also confirmed
that our htrA mutant is non-polar because genetic com-
plementation experiments with the corresponding WT gene
restored (i) expression of proteolytically active HtrA multimers
(Figures S1A,B), (ii) C. jejuni growth at high temperature (44◦C)
(Figures S2A,B) and (iii) growth under high oxygen stress con-
ditions (Figures S2A,C). Six days following peroral challenge all
mice harbored comparable pathogen loads with either strain
in the duodenum, ileum and colon, which is indicative for
an uncompromised colonization capacity of the htrA mutant
strain in vivo (Figure 1B). After 6 days 12.5% of IL-10−/−
mice infected with either the htrA mutant or the C. jejuni
WT strain contained viable pathogens also in MLNs as shown
by culture. Notably, bacterial presence in extra-intestinal com-
partments such as spleen, liver, kidney, or blood could not be
observed with either strain based on CFU determination (data
not shown).
Frontiers in Cellular and Infection Microbiology www.frontiersin.org June 2014 | Volume 4 | Article 77 | 4
Heimesaat et al. C. jejuni HtrA induced immunopathology
IMPACT OF HTRA ON ACUTE ENTEROCOLITIS IN C. JEJUNI INFECTED
GNOTOBIOTIC IL-10−/− MICE
Six days p.i. with the C. jejuni NCTC11168 WT strain, gno-
tobiotic IL-10−/− mice were decisively compromised by acute
enterocolitis as indicated by wasting clinical symptoms, diarrhea
and occurrence of blood in liquid feces in up to 90% of cases
(Figures 2A,B). In contrast, mice infected with thehtrAmutant
displayed significantly less severe clinical symptoms (p < 0.0005;
FIGURE 1 | C. jejuni colonization along the intestinal tract of
gnotobiotic IL-10−/− mice is independent of htrA gene expression.
(A) Control Western blots for the expression of indicated proteins in the
two C. jejuni strains used in this infection study. (B) Gnotobiotic IL-10−/−
mice were generated by broad-spectrum antibiotic treatment and perorally
infected with C. jejuni NCTC11168 wild-type strain (WT, closed circles) or
mutant strain NCTC11168htrA (htrA, open circles). The pathogen
densities in distinct compartments of the intestinal tract were determined
by quantification of live C. jejuni in luminal samples taken from duodenum,
ileum, and colon at day 6 p.i. by cultural analysis (CFU, colony forming
units). Medians (black bars) are indicated and numbers of analyzed animals
given in parentheses. Data shown were combined from five independent
experiments.
Figure 2A) and lower frequency of bloody diarrhea as compared
to controls infected with the WT strain (50.0 vs. 89.7%, respec-
tively; p < 0.001, Figure 2B). Given that intestinal inflammation
results in a significant shortening of the intestines (Heimesaat
et al., 2006; Bereswill et al., 2011; Haag et al., 2012a), we fur-
ther assessed the colonic lengths upon C. jejuni infection. At day
6 p.i., IL-10−/− mice infected with the htrA mutant displayed
longer colons as compared to WT strain infected control animals
(p < 0.05; Figure 2C). These results provide first evidence that
HtrA aggravates the inflammatory outcome of C. jejuni infec-
tion. This was further confirmed by histopathological analysis of
paraffin embedded colonic sections. Microscopical investigations
of H&E-stained tissues revealed that htrAmutant infected mice
displayed significantly lower histopathological scores as com-
pared to mice infected with the C. jejuni WT strain at day 6 p.i.
(p < 0.0001, Figure 2D). The htrAmutant induced rather mild
inflammatory changes whereas C. jejuni WT strain infected mice
exhibited acute enterocolitis characterized by ulcerations of and
bleeding into the colonicmucosa as well as by diffusemucosal and
submucosal leukocytic infiltrates, loss of goblet cells and crypt
drop-outs (Figure 2D).
HTRA TRIGGERS C. JEJUNI-MEDIATED INTESTINAL IMMUNE
RESPONSES
The role of C. jejuni HtrA in intestinal inflammation was next
assessed by microscopical quantification of apoptotic and prolif-
erating cells as well as infiltrating immune cells. This was achieved
by specific immunohistochemical stainings of colonic paraffin
sections. Six days following C. jejuni WT strain infection, gnoto-
biotic IL-10−/− mice displayed a multifold increase of apoptotic
cells, neutrophils, macrophages and monocytes, B and T lympho-
cytes as well as regulatory T cells (Treg) in the colonic mucosa and
lamina propria (p < 0.001 − 0.0001 as compared to naive control
animals; Figure 3). The induction of apoptosis and the increase
FIGURE 2 | Role of C. jejuni htrA gene in acute enterocolitis following
infection of gnotobiotic IL-10−/− mice. Six days following C. jejuni infection
(A) disease activity and (B) occurrence of blood in fecal samples was
assessed by applying respective standardized clinical scoring system.
Furthermore, (C) large intestinal lengths (in cm) were measured and (D)
histopathological changes applying a standardized histopathological score in
H&E-stained colonic paraffin sections were determined at necropsy. Means
(black bars), levels of significance (P-values) determined by the
Mann-Whitney-U-test, and numbers of analyzed animals (in parentheses) or
absolute and relative (in %) numbers of positive samples out of the total
number are indicated. Data shown were pooled from three independent
experiments.
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in inflammatory immune cells, however, were significantly less
pronounced in animals infected with the C. jejuni htrA mutant
except for the T cell and Treg populations (p < 0.05 − 0.0001
as compared to animals infected with the C. jejuni WT strain;
Figure 3). Given that Ki67 comprises a nuclear protein that is
associated with and necessary for cellular proliferation (Scholzen
and Gerdes, 2000), we stained colonic paraffin sections against
Ki67 to detect proliferative measures of the colonic epithelium
counteracting cellular destruction during the inflammatory pro-
cess. Interestingly, the htrAmutant induced significantly higher
numbers of Ki67+ proliferating cells as compared to the WT
strain (p < 0.05; Figure 3B).
The C. jejuni induced colonic immune cell responses were
accompanied by increased expression of pro-inflammatory
cytokines in the large intestine. Until day 6 p.i., levels, of IFN-γ
and IL-6 and, in addition, NOwere multifold increased in colonic
ex vivo biopsies upon C. jejuni infection. Cytokines increased to
a significantly lower extent in gnotobiotic IL-10−/− mice infected
with the htrA mutant as compared to WT strain infected mice
(p < 0.05 − 0.01; Figures 4A–C). In addition, C. jejuni infected
FIGURE 3 | Continued
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FIGURE 3 | Colonic inflammatory, regenerative, and immune cell
responses in gnotobiotic IL-10−/− mice following infection with
wild-type and htrA mutant C. jejuni. The average numbers of apoptotic
cells [positive for caspase-3, (A)], proliferating cells [positive for Ki67, (B)],
neutrophils [positive for MPO7, (C)], macrophages and monocytes [positive
for F4/80, (D)], T lymphocytes [positive for CD3, (E)], regulatory T cells [Treg,
positive for FOXP3; (F)], and B lymphocytes [positive for B220, (G)] from at
least six high power fields (HPF, 400× magnification) per animal were
determined microscopically in immunohistochemically stained colon sections
at day 6 p.i. Data were pooled from five independent experiments.
Representative photomicrographs of respectively stained cells are shown
(400× magnification, scale bar 20μm).
mice displayed increased NO secretion into drainingMLNs at day
6 p.i. as compared to uninfected controls. This increase, however,
was significantly lower inmice infected with thehtrAmutant vs.
the parental WT strain infected animals (p < 0.05; Figure 4D).
Given that a proper mucus layer is a pivotal barrier protecting
the intestinal epithelium from intestinal pathogens, we next deter-
mined the mRNA expression levels of mucin-2 (MUC-2), which
is mainly secreted from goblet cells in the epithelial lining of the
large intestine (Allen et al., 1998; Naughton et al., 2014). Six days
following C. jejuni infection of IL-10−/− mice, colonic mucin-2
mRNA was significantly downregulated by C. jejuni WT strain,
but to a lesser extent by the htrA knockout mutant (p < 0.05;
Figure 4E). Taken together, the less severe clinical, histopatholog-
ical and inflammatory outcome of enterocolitis in mice infected
with the C. jejuni htrA mutant strain was paralleled by a higher
mucin-2 expression level as compared to control animals infected
with the parental strain.
HTRA IS ALSO INVOLVED IN THE INDUCTION OF EXTRA-INTESTINAL
PRO-INFLAMMATORY IMMUNE RESPONSES IN C. JEJUNI INFECTED
GNOTOBIOTIC IL-10−/− MICE
We next investigated potential systemic pro-inflammatory
immune responses upon C. jejuni infection. At day 6 p.i. with
either strain, TNF-α and IL-6 serum levels were increased
as compared to naïve controls, but less distinctly in htrA
mutant strain infected mice (p < 0.005 and p < 0.05, respec-
tively; Figure 5). Hence, C. jejuni htrA knockout mutation not
only reduces intestinal but also systemic inflammatory responses
upon infection. Unexpectedly, 6 days following infection with
the htrA gene mutant but not the WT strain, IFN-γ, TNF-α,
and NO levels were up-regulated in splenic ex vivo biopsies
(p < 0.05 − 0.0005; Figures 6A–C). Furthermore, secretion of
IL-6 into spleens were higher following htrA mutant infection
as compared to the parental strain at day 6 p.i. (p < 0.0001,
Figure 6D).
We have recently shown that following long-term C. jejuni
infection (i.e., more than 100 days p.i.) conventionally colo-
nized infant mice exhibited pro-inflammatory immune responses
at extra-intestinal locations such as liver and kidneys (Haag
et al., 2012b; Heimesaat et al., 2013). We were therefore inter-
ested to investigate whether extra-intestinal sequelae might arise
even after relatively short-term C. jejuni infection of gnotobiotic
IL-10−/− mice suffering from acute enterocolitis. To address this
idea, we assessed inflammatory changes in H&E-stained paraffin
sections of liver and kidneys. Six days following C. jejuni infection
with either strain mice displayed only minimal to mild lobular
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FIGURE 4 | Importance of C. jejuni htrA gene expression in intestinal
pro-inflammatory cytokine responses and mucin-2 expression
induced during infection of gnotobiotic IL-10−/− mice. Colonic (A)
nitric oxide, (B) IFN-γ, and (C) IL-6 levels, (D) nitric oxide concentrations
in mesenteric lymph nodes (MLN), and (E) large intestinal mucin-2
(MUC-2) mRNA expression levels were determined in respective ex vivo
biopsies taken at day 6 p.i. Data shown were combined from three
independent experiments.
FIGURE 5 | Systemic pro-inflammatory cytokine responses following
C. jejuni infection of gnotobiotic IL-10−/− mice. (A) TNF-α and (B) IL-6
levels were determined in serum samples taken at day 6 p.i. Data shown
were pooled from five independent experiments.
and/or portal inflammatory infiltrates in livers and mild focal
hypercellularity in kidneys (Figure 7).
We next determined pro-inflammatory cytokine responses in
ex vivo biopsies from liver and kidneys upon C. jejuni infection
of gnotobiotic IL-10−/− mice. Six days following C. jejuni infec-
tion hepatic IFN-γ, TNF-α, and IL-6 concentrations increased
(p < 0.05 − 0.0001; Figures 8A–C), but to even higher levels
upon htrA knockout mutant as compared to parental C. jejuni
WT strain infection (p < 0.05; Figures 8A–C). Notably, the stan-
dard deviation in the cohort infected with the htrA gene
knockout mutant was rather high. Interestingly, hepatic NO levels
increased 6 days following WT infection, but not during htrA
mutant strain infection (p < 0.05; Figure 8D), which helds also
true for NO secretion in ex vivo biopsies taken from kidneys (p <
0.05; Figure 8E). Furthermore, TNF-α levels increased in kid-
neys of C. jejuni infected IL-10−/− mice (p < 0.0001; Figure 8F),
but less distinctly in the htrA knockout mutant infected group
(p < 0.05; Figure 8F). Taken together, even as early as 6 days fol-
lowing C. jejuni infection pro-inflammatory immune responses
could be detected in extra-intestinal compartments such as liver
and kidneys that were even more pronounced in livers, but less
distinct in kidneys of htrA mutant as compared to parental WT
strain infected IL-10−/− mice suffering from acute enterocolitis.
DISCUSSION
The mucosa in the intestine of mammals forms a tight bar-
rier, which protects against commensals and other microbes
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FIGURE 6 | Pro-inflammatory cytokine responses in spleens following C. jejuni infection of gnotobiotic IL-10−/− mice. Splenic (A) IFN-γ, (B) TNF-α, (C)
nitric oxide, and (D) IL-6 levels were determined in supernatants of ex vivo biopsies taken at day 6 p.i. Data shownwere pooled from five independent experiments.
FIGURE 7 | Extra-intestinal immunopathological sequelae following
C. jejuni infection of gnotobiotic IL-10−/− mice. Six days following C. jejuni
infection extra-intestinal immunopathological sequelae were assessed in
H&E-stained paraffin sections of (A) liver and (B) kidneys by applying
respective standardized clinical scoring system and illustrated by
representative photomicrographs (400× magnification, scale bar 20μm). In
liver sections, black arrow heads indicate portal and white arrow head lobular
inflammatory infiltrates. In kidney sections, black arrow heads point to focal
hypercellularity. Data shown were combined from three independent
experiments.
present in the intestinal lumen. Previous infection studies in
mice have revealed that mutation of the serine protease HtrA
in a number of pathogenic bacteria results in attenuated vir-
ulence properties (Li et al., 1996; Humphreys et al., 1999;
Wilson et al., 2006; Yuan et al., 2008; Lewis et al., 2009;
De Stoppelaar et al., 2013). Bacterial HtrA may be involved
in degradation of damaged bacterial proteins that accumulate
during the hostile conditions in the macrophages and accord-
ingly, htrA mutants of the facultative intracellular Salmonella
typhimurium, Listeria monocytogenes, and Yersinia enterocolitica
are all sensitive to oxidative agents and show reduced sur-
vival rates in macrophages (Bäumler et al., 1994; Yamamoto
et al., 1996; Wilson et al., 2006). The individual contribu-
tion of chaperone and protease activity of HtrA to bacte-
rial survival and multiplication in the host is difficult to dis-
sect. However, for S. typhimurium, both activities appear to be
required for proper systemic infection in mice (Lewis et al.,
2009). Interestingly, after oral infection with an htrA mutant,
the pathogen cannot translocate accurately from the Peyer’s
patches to other organs. In contrast, intravenous infection of
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FIGURE 8 | Pro-inflammatory cytokine responses in livers and kidneys
of gnotobiotic IL-10−/− mice infected with C. jejuni. Hepatic (A) IFN-γ,
(B) TNF-α, (C) IL-6, (D) nitric oxide levels, and renal (E) nitric oxide, and
(F) TNF-α levels were determined in supernatants of ex vivo biopsies
taken at day 6 p.i. Data shown were pooled from at least three
independent experiments.
mice resulted in full colonization of livers and spleens by the
S. typhimurium htrA mutant, suggesting that HtrA is required
to overcome the intestinal barrier (Humphreys et al., 1999).
Expression of HtrA is also important for cell-to-cell spread of
Shigella flexneri (Purdy et al., 2002, 2007). Previous in vitro
infection studies with C. jejuni have indicated that inactivation
of htrA reduced the bacterial adherence to cultured epithe-
lial cells (Brøndsted et al., 2005). In addition, C. jejuni htrA
mutants exhibited reduced invasion rates (Novik et al., 2010;
Bæk et al., 2011a). Interestingly, HtrA chaperone activity appears
to be important for efficient binding of C. jejuni to epithe-
lial cells, while the HtrA protease activity seems required for
maximal host cell entry after the bacteria have adhered to
them (Bæk et al., 2011a). Under laboratory conditions in vitro,
HtrA chaperone activity is necessary for growth of C. jejuni at
high temperatures or under oxidative stress conditions, whereas
HtrA protease activity is only essential during severe stress
(Bæk et al., 2011b).
We have recently shown in a series of in vitro experiments
that HtrA secreted by C. jejuni constitutes a novel bacterial vir-
ulence determinant, which opens cell-to-cell junctions through
cleavage of E-cadherin and probably other host factors (Boehm
et al., 2012, 2013; Hoy et al., 2012). In the present study, we
investigated for the first time the impact of the htrA gene in
C. jejuni-induced immunopathology in vivo and applied the acute
C. jejuni infection model of gnotobiotic IL-10−/− mice. To pre-
vent conventionally colonized IL-10−/− mice from chronic colitis
exerted by antigenic stimuli through the conventional intestinal
microbiota, mice were pre-treated for 4 months with a quintu-
ple antibiotic regimen starting immediately after weaning (Haag
et al., 2012a). Six days following peroral infection with C. jejuni,
mice harbored high intestinal loads of the non-polar knock-
out mutant strain NCTC11168htrA, which were comparable
to those detected in mice upon infection with the parental WT
strain NCTC11168. Hence, inactivation of the htrA gene did not
down-regulate the overall high colonization capacity of C. jejuni
in gnotobiotic mice. At first sight, these data seem to contradict
a previous report where HtrA chaperone activity was shown to
be required for efficient binding of C. jejuni to cultured INT-407
epithelial cells (Bæk et al., 2011a). However, INT-407 cells do not
form polarized cell layers, while polarized epithelial cell layers are
found in the intestine of live mice. Thus, the receptor availability
in both systems is certainly different, which could be one reason
to explain these findings.
Importantly, gnotobiotic IL-10−/− mice infected with the
parental WT strain were severely compromised and developed
ulcerative enterocolitis with bloody diarrhea and wasting symp-
toms, hence mimicking severe campylobacteriosis in immuno-
compromised patients (Haag et al., 2012a). Remarkably, at day
6 p.i. ulcerative enterocolitis was less distinct in mice infected
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with the htrA mutant, which displayed significantly less severe
immunopathology in the intestinal tract as compared to mice
infected with theC. jejuniWT strain. Interestingly,htrAmutant
infected mice exhibited higher Ki67+ proliferating cell num-
bers in the colonic mucosa as compared to WT strain infected
controls. This might be indicative for up-regulated compen-
satory properties in order to counteract cell destruction during
immunopathology. Furthermore, not only local, but even sys-
temic immune responses were less pronounced upon htrA
mutant infection as indicated by significant lower serum lev-
els of pro-inflammatory cytokines such as TNF-α and IL-6 in
htrAmutant as compared toWT strain infected mice. The ame-
lioration of devastating enteric and systemic disease, as in this
hyper-acute model system, underlines the biological relevance of
individual C. jejuni virulence factors in vivo. Furthermore, in the
present and previous infection studies with conventional infant,
germfree or with human microbiota re-associated germfree WT
mice (Bereswill et al., 2011; Haag et al., 2012b), translocation of
viable C. jejuni of either strain from the intestine to the MLNs
could be observed in a subset of animals, whereas no bacte-
rial CFUs could be cultured from extra-intestinal locations such
as spleen, liver, kidney, or cardiac blood. This is good agree-
ment with the observation of very rare cases of extra-intestinal
C. jejuni-associated disease affecting the liver, lung, heart, or
spleen that have been reported in immunocompromised patients
suffering from C. jejuni bacteremia (Pigrau et al., 1997; Tee and
Mijch, 1998; Crushell et al., 2004) and previous infection studies
of isolator-raised germfree mice (Fauchère et al., 1985). Whereas
viable C. jejuni could be cultured from MLNs of infected mice
more than 3 weeks p.i., the pathogen was cleared from the cir-
culation and extra-intestinal organs such as liver and spleen
within 24 h. The authors proposed that non-specific bacterici-
dal factors such as complement or phagocytic cells might have
been responsible for rapid pathogenic clearance. However, the
histopathological sequelae within the respective organs were not
reported (Fauchère et al., 1985). Surprisingly, in the present
study histopathological analysis revealed rather mild inflamma-
tory changes in extra-intestinal organs such as liver and kidneys
that did not differ 6 days p.i. with either C. jejuni strain. In gno-
tobiotic WT mice, however, which can be readily colonized by
C. jejuni, we did not observe any overt extra-intestinal histopatho-
logical changes in respective H&E stained paraffin sections by
day 42 p.i. (unpublished observations). It is therefore most likely
that a significant intestinal pro-inflammatory scenario (as seen
in the gnotobiotic IL-10−/− mouse model) is a prerequisite for
subsequently induced extra-intestinal inflammatory responses as
shown in the present study. In line with this, in another infec-
tion model, 3 weeks old infant mice (harboring a conventional
microbiota) were infected with C. jejuni B2 strain immediately
after weaning and exhibited histopathological sequelae in liver,
kidneys, lungs, and cardiac muscle more than 100 days follow-
ing C. jejuni infection (Haag et al., 2012b). Interestingly, mice
were asymptomatic C. jejuni carriers until day 103 p.i. and the
extra-intestinal organs were exclusively C. jejuni culture neg-
ative (Haag et al., 2012b). Furthermore, the vast majority of
inflammatory cells that had accumulated in the respective extra-
intestinal organs comprised CD3+ T lymphocytes (Heimesaat
et al., 2013). It is highly likely that pro-inflammatory immune
cells have been attracted to the site of infection and cleared the
pathogen early in the course of infection and reside further in
the respective organ. This would explain the sterile inflamma-
tory responses in liver and kidneys, both in less than 1 week
(this study) and more than 3 months p.i. (Haag et al., 2012b;
Heimesaat et al., 2013). Hence, the influx of pro-inflammatory
immune cells upon even short-term C. jejuni infection might
explain the increased levels of pro-inflammatory cytokines such
as IFN-γ, IL-6, TNF-α, and NO detected in livers and the lat-
ter two in kidneys at day 6 p.i. Like in the colon, renal TNF-α
and NO as well as hepatic NO levels were significantly lower in
htrA knockout mutant as compared to parental strain infected
gnotobiotic IL-10−/− mice at day 6 p.i. Unexpectedly, IFN-γ,
IL-6, and TNF-α concentrations in spleen and liver were even
higher 6 days following htrA knockout mutant as compared to
parental WT strain infection. Notably, the standard deviations in
the cohorts infected with the htrA gene knockout mutant were
rather high, which held true for individual experiments as well
as for pooled data sets. Hence, the individual variabilities upon
infection needs to take into account when judging for the bio-
logical relevance of the observed effects in the absence of htrA.
In line with these unexpected data derived from livers of infected
mice, splenic IFN-γ, IL-6, and TNF-α levels increased only upon
htrA knockout mutant, but not parental WT strain infection
when compared to naive controls. It is therefore tempting to spec-
ulate whether in the course of the observed systemic immune
responses more immune cells (such as dendritic cells and/or lym-
phocytes) might have been activated/imprinted in the spleen by
the C. jejuni htrA mutant present in the intestine as com-
pared to parental WT strain infection or stimulated by distinct
(so far unknown) circulating soluble bacterial factors derived
from the pathogen which in turn could counteract intestinal dis-
ease. Further studies need to unravel this fascinating infection
phenomenon.
Taken together, C. jejuni is one of the most important zoonotic
pathogens causing food-borne gastroenteritis and potentially
more severe diseases. Crossing the intestinal epithelial barrier
and host cell invasion by C. jejuni are considered to consti-
tute primary reasons of gut tissue damage in humans. However,
the molecular mechanisms as well as major bacterial and host
cell factors involved in these activities are poorly understood.
Using the IL-10−/− knockout mouse infection model system,
the results presented in this study demonstrate for the first time
that the C. jejuni HtrA serine protease is a novel virulence fac-
tor which aggravates enterocolitis in situ by causing a substantial
amount of cell damage, aggravation of intestinal apoptosis and
inflammation upon C. jejuni infection in vivo accompanied by
significant systemic pro-inflammatory immune responses. These
observations are in line with our earlier in vitro studies show-
ing that HtrA of C. jejuni targets epithelial E-cadherin-based
cell-to-cell junctions (Boehm et al., 2012, 2013; Hoy et al.,
2012). Future work should address important questions such
as how C. jejuni can trigger HtrA secretion into the extracellu-
lar space, to identify E-cadherin cleavage sites by HtrA and to
search for novel host cell targets involved in the above discov-
ered activities in vivo. We further demonstrated non-polarity of
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the htrA knockout mutant strain by complementation of phe-
notypes in vitro; however, this does not warranty non-polarity
of the mutation in vivo. The investigation of epithelium-bound
or internalized C. jejuni in ongoing studies will further complete
our understanding of the complex interactions of HtrA with the
epithelium.
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Figure S1 | Genetic complementation of HtrA reveals that the C. jejuni
NCTC11168htrA mutant is non-polar. (A) Expression of HtrA proteins by
C. jejuni NCTC11168 wild-type (WT), NCTC11168htrA mutant and
complemented NCTC11168htrA/htrA were investigated by Western
blotting using an α-HtrA antibody. As control, equal amounts of protein per
sample were confirmed by immunoblotting using the α-MOMP
antibody.
(B) Analysis of protease activities in all three indicated strains by casein
zymography. The position of proteolytically active multimeric HtrA proteins
is indicated with arrows.
Figure S2 | Effect of high temperature and oxygen concentration on
growth of the C. jejuni htrA mutant and genetically complemented htrA
strain. Serial dilutions (10−1, 10−2, 10−3, 10−4, 10−5, and 10−6) of the
indicated C. jejuni strains [NCTC11168 wild-type (WT), NCTC11168htrA
and complemented NCTC11168htrA/htrA] with an OD600 of 0.1 were
spotted in 10μl volumes onto Müller-Hinton agar plates. The plates were
incubated for 3 days in jars under microaerobic conditions at (A) 42◦C, (B)
44◦C, or (C) 42◦C in the presence of 18% O2. Representative sections of
the agar plates from three independent experiments are
presented.
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